Edwards Lifesciences CVP Daniel Lippis Sells $54,168 in Stock
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowDaniel Lippis, Chief Vice President of Edwards Lifesciences, sold $54,168 worth of stock in a recent transaction. The sale involved 1,125 shares, priced at approximately $48.10 per share. This event occurred within the framework of routine stock transactions by company insiders. Such insider trading activities can signal confidence or concerns about the company, influencing investor perceptions and market sentiment around Edwards Lifesciences (EW).
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Edwards Lifesciences (EW)
Edwards Lifesciences specializes in heart-valve and critical-care devices.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier EW news
- Edwards Lifesciences Corp (EW) Form 4 Filing on July 30
- Edwards Lifesciences Corp (EW) Form 4 Filing on July 27
- Edwards Lifesciences CEO Sells $245,134 in Shares
- Edwards Lifesciences (EW) CFO Ullem sells $1M in company shares
- Edwards Lifesciences Trading at $83.92 with Strong Growth Prospects
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
